Assignee
ANGES MG INC
JP·19 granted patents·19 pending applications·158 citations·filing 2000–2016
Top patents by PatentIndex Score
38 records- 0186US7345158B2Actin related cytoskeletal protein “LACS”ANGES MG INC·Filed 2003·Granted Mar 18, 2008·63 cites·4 claims
- 0284US7285540B2Medicament comprising HGF geneANGES MG INC·Filed 2003·Granted Oct 23, 2007·20 cites·4 claims
- 0384US6913923B2Virus envelope vector for gene transferANGES MG INC·Filed 2001·Granted Jul 5, 2005·16 cites·7 claims
- 0480US7803621B2Virus envelope vector for gene transferANGES MG INC·Filed 2005·Granted Sep 28, 2010·3 cites·17 claims
- 0576US7279333B2Virus envelope vector for gene transferANGES MG INC·Filed 2004·Granted Oct 9, 2007·6 cites·11 claims
- 0676US6989374B1Gene therapy for cardiomyopathyANGES MG INC·Filed 2000·Granted Jan 24, 2006·11 cites·4 claims
- 0775US7994151B2Compositions and methods for angiogenic therapy utilizing genes encoding ets-1ANGES MG INC·Filed 2009·Granted Aug 9, 2011·1 cites·12 claims
- 0875US7247620B2Method of treating skin wounds with vectors encoding hepatocyte growth factorANGES MG INC·Filed 2002·Granted Jul 24, 2007·6 cites·7 claims
- 0974US7595301B2Staple type oligonucleotide and drug comprising the sameANGES MG INC·Filed 2004·Granted Sep 29, 2009·12 cites·3 claims
- 1074US6936594B1Gene therapy for cerebrovascular disordersANGES MG INC·Filed 2000·Granted Aug 30, 2005·8 cites·5 claims
- 1173US7504098B2Method for introducing a biological molecule using a viral envelope and heparin and system thereforeANGES MG INC·Filed 2005·Granted Mar 17, 2009·2 cites·2 claims
- 1271US7871983B2Remedy and preventive for diseases caused by NF-κBANGES MG INC·Filed 2003·Granted Jan 18, 2011·2 cites·14 claims
- 1371US7524830B2Decoy-containing pharmaceutical compositions and method of using the sameANGES MG INC·Filed 2006·Granted Apr 28, 2009·1 cites·3 claims
- 1470US7763591B2Hepatocyte growth factor gene therapy for parkinson's diseaseANGES MG INC·Filed 2002·Granted Jul 27, 2010·4 cites·12 claims
- 1568US2011160132A1Lymphangiogenesis-promoting agentsANGES MG INC·Filed 2006·Application pending·0 cites
- 1667US7939504B2Method of treating skin ulcers with vectors encoding hepatocyte growth factorANGES MG INC·Filed 2007·Granted May 10, 2011·0 cites·7 claims
- 1763US7390482B2Drug for auditory dysfunctionANGES MG INC·Filed 2003·Granted Jun 24, 2008·1 cites·2 claims
- 1862US7259149B2Methods for treating or preventing angiogenesis-dependent symptomsANGES MG INC·Filed 2003·Granted Aug 21, 2007·2 cites·4 claims
- 1960US9889186B2Oral vaccine having improved cellular immunity induction potencyANGES MG INC·Filed 2014·Granted Feb 13, 2018·0 cites·16 claims
- 2060US2009004260A1Medicament comprising hgf geneANGES MG INC·Filed 2008·Application pending·0 cites
- 2157US2011045061A1Gene therapy for diabetic ischemic diseaseANGES MG INC·Filed 2010·Application pending·0 cites
- 2257US2009105183A1Pharmaceutical composition containing decoy and method of using the sameANGES MG INC·Filed 2008·Application pending·0 cites
- 2356US2016271219A1Lymphangiogenesis-promoting agentsANGES MG INC·Filed 2016·Application pending·0 cites
- 2456US2008213348A1Agents for gene therapy of cerebrovascular disordersANGES MG INC·Filed 2008·Application pending·0 cites
- 2556US2006116344A1Remedy and preventive for diseases caused by NF-kBANGES MG INC·Filed 2006·Application pending·0 cites
- 2654US2006263422A1Pharmaceutical composition containing decoy and use of the sameANGES MG INC·Filed 2006·Application pending·0 cites
- 2754US2008207552A1Decoy compositions for treating and preventing brain diseases and disordersANGES MG INC·Filed 2007·Application pending·0 cites
- 2852US2009215868A1Therapeutic Medicament for Chronic Obstructive Pulmonary Disease (COPD), Cystic Fibrosis, and Pulmonary HypertensionANGES MG INC·Filed 2006·Application pending·0 cites
- 2951US2008312145A1Agent for Regulating Bone FormationANGES MG INC·Filed 2005·Application pending·0 cites
- 3050US2006234969A1Compositions and methods for inhibiting inflammation of vessel walls and formation of neointimal hyperplasiaANGES MG INC·Filed 2004·Application pending·0 cites
- 3148US2016250290A1Gene therapy for diabetic ischemic diseaseANGES MG INC·Filed 2015·Application pending·0 cites
- 3244US2004087535A1Pharmaceutical composition for angiogenesisANGES MG INC·Filed 2003·Application pending·0 cites
- 3344US2010311823A1Agent for regulating bone formationANGES MG INC·Filed 2010·Application pending·0 cites
- 3444US2005080140A1Method for treating or preventing inflammatory disordersANGES MG INC·Filed 2004·Application pending·0 cites
- 3542US2006233815A1Agents for protection from neointimal formation in grafts comprising an nfkappab decoyANGES MG INC·Filed 2002·Application pending·0 cites
- 3640US2009082263A1Drug and method for improving brain functionANGES MG INC·Filed 2005·Application pending·0 cites
- 3738US2006134078A1Method for culturing neural stem cells using hepatocyte growth factorANGES MG INC·Filed 2003·Application pending·0 cites
- 3834US7790692B2Hepatocyte growth factor nucleic acid sequence to enhance musculocutaneous flap survivalANGES MG INC·Filed 2005·Granted Sep 7, 2010·0 cites·12 claims
Join the waitlist — get patent alerts
Get an alert when ANGES MG INC files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →